Aetna Inc.

Gregory Brian Steinberg

Henry George Wei

Rajesh Revachand Mehta

Leonard Naar

Brian Garcia

Aaron Sklar

A method and system for analyzing a relationship between agents and clinical outcomes is disclosed. The method includes: receiving a selection of one or more agents; receiving a selection of one or more clinical outcomes; for each of the one or more agents, analyzing clinical data stored in a database to determine a number of occurrences of each of the one or more clinical outcomes when the agent is administered; for each of the one or more agents, calculating a risk score for each clinical outcome corresponding to the number of occurrences of the clinical outcome; and outputting the risk scores to a graphical display. The displayed information can also be scaled and filtered for ease of use. Also, the results may be stratified into sub-populations.

System and method for pharmacovigilance

A system and method including: receiving medical data related to a patient; identifying two or more assessments to be performed by a case manager based on the medical data, each including a different set of questions to be answered by the patient, and each set of questions is directed to a different medical condition that the patient is at risk of having based on the medical data; prioritizing the two or more assessments based on the medical data and additional input from the case manager; displaying, in a user interface of a case manager terminal, a listing of questions from the highest priority assessment; receiving a response to a first question; reprioritizing the two or more assessments based on the response; and, displaying, in the user interface, a listing of unanswered questions from the set of questions included in the assessment having the highest priority based on the reprioritizing.

Systems and methods for patient health assessment

Computer display with graphical user interface for a pharmacovigilance tool

A method, computer-readable storage medium, and system for analyzing a relationship between one or more agents and one or more clinical outcomes. The method includes: receiving a selection of one or more agents; receiving a selection of one or more clinical outcomes; for each of the one or more agents, analyzing clinical data stored in a database to determine a number of occurrences of each of the one or more clinical outcomes when the agent is administered; for each of the one or more agents, calculating a risk score for each clinical outcome corresponding to the number of occurrences of the clinical outcome; and outputting the risk scores to a graphical display.

Growing community of inventors

Dingmans Ferry, PA, United States of America

Gregory Brian Steinberg